Gorlin Syndrome, Vulvar Basal Cell Carcinomas, Vismodegib, and Lichen Sclerosus: From the ISSVD Case Consultation Committee.
Emily R Kirkpatrick,D. Dobriansky,J. Scurry
DOI: https://doi.org/10.1097/LGT.0000000000000209
2016-07-01
Journal of Lower Genital Tract Disease
Abstract:FIGURE 1. A, Thirty-four months before vismodegib. Scarcely visible papules and nodules on the vulva. An excoriated nodule is arrowed. Some pallor and skin thickening are present, but the labium minus is preserved. B, Thirty-four months before vismodegib, a superficial basal cell carcinoma is present (arrow), but there is no lichen sclerosus in the adjacent skin (hematoxylin-eosin (H&E); original magnification, 200). CASE REPORT A 70-year-old woman first presented with recurrent odontogenic cysts at the age of 16 years. Her schooling was interrupted by long periods of hospitalization required for jaw and dental treatment. At 26 years, she developed a basal cell carcinoma (BCC) on her nose at which time a clinical diagnosis of Gorlin syndrome (GS) was made. When aged 40 years, she had her first of many vulvar BCC diagnosed on biopsy. Since then, she has had numerous excisions for her estimate of 50 to 100 vulvar BCC, which required a local flap repair on some occasions. Her BCC presented as pruritic and occasionally painful small erythematous macules, best identified with the colposcope, and larger often excoriated papules up to 5 mm in diameter. The distribution of her vulvar BCC was on the non–hair-bearing skin of the labia minora, interlabial sulcus, and clitoral hood and more in the anterior vulva than posterior (Fig. 1). Patient consent obtained. Extragenitally, she has had many hundreds of BCC excised, distributed on her face, back, and limbs but sparing the abdomen. Pathology of the vulvar excisions showed superficial, nodular, and occasionally infiltrative BCC (Fig. 1). Before 2012, no lichen sclerosus was seen in adjacent skin in any of the excisions of BCC. In 2012, however, she had 3 excisions which all showed lichen sclerosus and BCC (Fig. 2). A year later, she was symptomatic again with BCC, but instead of having excisions, she began vismodegib 150 mg daily. Within a few weeks of commencing vismodegib, all macules and papules on the vulva and elsewhere had disappeared, and there was no pruritus. Tissue sent for pathology from a reconstruction of the vulva showed lichen sclerosus but no BCC (Fig. 3).